(Q34025582)

English

A meta-analysis of the effect of strontium ranelate on the risk of vertebral and non-vertebral fracture in postmenopausal osteoporosis and the interaction with FRAX(®).

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

30 July 2017

0 references

A meta-analysis of the effect of strontium ranelate on the risk of vertebral and non-vertebral fracture in postmenopausal osteoporosis and the interaction with FRAX(®). (English)

1 reference

Europe PubMed Central

30 July 2017

0 references

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

postmenopausal osteoporosis

1 reference

based on heuristic

inferred from title

author name string

J A Kanis

1

1 reference

Europe PubMed Central

30 July 2017

H Johansson

2

1 reference

Europe PubMed Central

30 July 2017

A Oden

3

1 reference

Europe PubMed Central

30 July 2017

E V McCloskey

4

1 reference

Europe PubMed Central

30 July 2017

language of work or name

0 references

publication date

2 February 2011

1 reference

Europe PubMed Central

30 July 2017

Osteoporosis International

1 reference

Europe PubMed Central

30 July 2017

22

1 reference

Europe PubMed Central

30 July 2017

8

1 reference

Europe PubMed Central

30 July 2017

2347-2355

1 reference

Europe PubMed Central

30 July 2017

https://scigraph.springernature.com/pub.10.1007/s00198-010-1474-0

0 references

The calcium-sensing receptor (CaR) is involved in strontium ranelate-induced osteoblast proliferation

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1474-0

21 January 2018

The calcium-sensing receptor is involved in strontium ranelate-induced osteoclast apoptosis. New insights into the associated signaling pathways

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1474-0

21 January 2018

Osteoblasts play key roles in the mechanisms of action of strontium ranelate

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1474-0

21 January 2018

Mechanisms of action and therapeutic potential of strontium in bone

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1474-0

21 January 2018

An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient rats.

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1474-0

21 January 2018

Strontium ranelate inhibits bone resorption while maintaining bone formation in alveolar bone in monkeys (Macaca fascicularis).

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1474-0

21 January 2018

Strontium ranelate improves bone resistance by increasing bone mass and improving architecture in intact female rats

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1474-0

21 January 2018

Strontium ranelate treatment improves trabecular and cortical intrinsic bone tissue quality, a determinant of bone strength.

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1474-0

21 January 2018

Strontium ranelate improves bone strength in ovariectomized rat by positively influencing bone resistance determinants

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1474-0

21 January 2018

The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1474-0

21 January 2018

Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study.

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1474-0

21 January 2018

Comparative effects of teriparatide and strontium ranelate on bone biopsies and biochemical markers of bone turnover in postmenopausal women with osteoporosis

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1474-0

21 January 2018

Histomorphometric and microCT analysis of bone biopsies from postmenopausal osteoporotic women treated with strontium ranelate.

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1474-0

21 January 2018

Could strontium ranelate have a synergistic role in the treatment of osteoporosis?

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1474-0

21 January 2018

Strontium ranelate: dose-dependent effects in established postmenopausal vertebral osteoporosis--a 2-year randomized placebo controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1474-0

21 January 2018

Effects of long-term strontium ranelate treatment on vertebral fracture risk in postmenopausal women with osteoporosis

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1474-0

21 January 2018

Ten-year fracture probability identifies women who will benefit from clodronate therapy--additional results from a double-blind, placebo-controlled randomised study

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1474-0

21 January 2018

Bazedoxifene reduces vertebral and clinical fractures in postmenopausal women at high risk assessed with FRAX.

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1474-0

21 January 2018

FRAX and the assessment of fracture probability in men and women from the UK

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1474-0

21 January 2018

Updated data on proximal femur bone mineral levels of US adults

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1474-0

21 January 2018

Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis The Study of Osteoporotic Fractures Research Group

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1474-0

21 January 2018

Vertebral fracture assessment using a semiquantitative technique.

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1474-0

21 January 2018

The potential impact of new National Osteoporosis Foundation guidance on treatment patterns

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1474-0

21 January 2018

The burden of osteoporotic fractures: a method for setting intervention thresholds

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1474-0

21 January 2018

Vertebral anti-fracture efficacy of strontium ranelate according to pre-treatment bone turnover

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1474-0

21 January 2018

An estimate of the worldwide prevalence and disability associated with osteoporotic fractures

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1474-0

21 January 2018

Vertebral fracture risk reduction with strontium ranelate in women with postmenopausal osteoporosis is independent of baseline risk factors

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1474-0

21 January 2018

A meta-analysis of the efficacy of raloxifene on all clinical and vertebral fractures and its dependency on FRAX.

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1474-0

21 January 2018

The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women.

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1474-0

21 January 2018

Statistical methods in cancer research. Volume II--The design and analysis of cohort studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/21287148

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clodronate reduces the incidence of fractures in community-dwelling elderly women unselected for osteoporosis: results of a double-blind, placebo-controlled randomized study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21287148

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00198-010-1474-0

1 reference

Europe PubMed Central

30 July 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

30 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34025582&oldid=1977863934"